Apr 30, 2024
13:10
For every 10 shares held, investors received 13. The price per share adjusted from $47.58 to $36.60.
The split itself did not change the total investment value.
Tibet Rhodiola Pharmaceutical Holding Co. Class A (SSE:600211) operates in the Pharmaceuticals: major industry.
Tibet Rhodiola Pharmaceutical Holding Co. Class A company overviewTibet Rhodiola Pharmaceutical Holding Co. Class A's most recent stock split was on April 30, 2024. It was a 13-for-10 forward split, so shareholders received 13 shares for every 10 they held.
Tibet Rhodiola Pharmaceutical Holding Co. Class A (SSE:600211) has split its stock 4 times: a 679-for-500 split on September 11, 2007, a 11-for-10 split on September 8, 2010, a 7-for-5 split on April 17, 2020, and a 13-for-10 split on April 30, 2024.
Tibet Rhodiola Pharmaceutical Holding Co. Class A has split its stock 4 times. This history records 4 forward splits between September 11, 2007 and April 30, 2024.
A stock split divides each share into more shares and lowers the price per share by the same factor, so the total value of a holding does not change. In Tibet Rhodiola Pharmaceutical Holding Co. Class A's 13-for-10 split on April 30, 2024, every 10 shares became 13 shares.
Tibet Rhodiola Pharmaceutical Holding Co. Class A has not announced a new split in our records. Its most recent split was on April 30, 2024, 2 years ago. Companies announce splits in advance, and any new SSE:600211 split will appear on this page.
Already premium?